Recent innovations in the screening and diagnosis of systemic sclerosis-associated interstitial lung disease.
Ashima MakolVivek NagarajaChiemezie AmadiJanelle Vu PugashettiElaine CaoiliZsuzsanna H McMahanPublished in: Expert review of clinical immunology (2023)
There is remarkable progress in the development of new radiomics and serum biomarkers in diagnosing SSc-ILD. There is an urgent need for conceptualizing and testing composite ILD screening strategies that incorporate these biomarkers.